HLA-B, major histocompatibility complex, class I, B, 3106
N. diseases: 706; N. variants: 308
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.120 | 6 | 31285148 | intron variant | C/T | snv | 0.12 |
|
Skin and Connective Tissue Diseases | 0.830 | 1.000 | 5 | 2009 | 2015 | |||||||
|
0.851 | 0.040 | 6 | 31291060 | intron variant | G/A | snv | 0.44 |
|
Skin and Connective Tissue Diseases | 0.820 | 1.000 | 3 | 2010 | 2012 | |||||||
|
0.807 | 0.200 | 6 | 31306778 | intron variant | C/T | snv | 0.12 |
|
Skin and Connective Tissue Diseases | 0.810 | 1.000 | 4 | 2008 | 2018 | |||||||
|
6 | 31274397 | intron variant | G/A | snv | 0.44 |
|
0.800 | 1.000 | 4 | 2011 | 2019 | ||||||||||
|
0.882 | 0.160 | 6 | 31297713 | intron variant | T/C | snv | 0.80 |
|
0.800 | 1.000 | 2 | 2010 | 2018 | ||||||||
|
0.925 | 0.040 | 6 | 31354782 | non coding transcript exon variant | G/A | snv | 0.19 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.925 | 0.040 | 6 | 31354782 | non coding transcript exon variant | G/A | snv | 0.19 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.925 | 0.040 | 6 | 31354782 | non coding transcript exon variant | G/A | snv | 0.19 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.925 | 0.040 | 6 | 31354782 | non coding transcript exon variant | G/A | snv | 0.19 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.851 | 0.280 | 6 | 31344549 | intron variant | T/G | snv | 8.8E-02 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 2 | 2007 | 2008 | |||||||
|
1.000 | 6 | 31354590 | non coding transcript exon variant | T/G | snv | 7.7E-02 | 2.3E-02 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.763 | 0.400 | 6 | 31306603 | intron variant | T/C | snv | 0.34 |
|
Digestive System Diseases | 0.800 | 1.000 | 2 | 2012 | 2015 | |||||||
|
0.763 | 0.400 | 6 | 31306603 | intron variant | T/C | snv | 0.34 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.763 | 0.400 | 6 | 31306603 | intron variant | T/C | snv | 0.34 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.763 | 0.400 | 6 | 31306603 | intron variant | T/C | snv | 0.34 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.763 | 0.400 | 6 | 31306603 | intron variant | T/C | snv | 0.34 |
|
0.800 | 1.000 | 2 | 2009 | 2010 | ||||||||
|
0.807 | 0.200 | 6 | 31306778 | intron variant | C/T | snv | 0.12 |
|
Infections; Immune System Diseases | 0.800 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 6 | 31273332 | intron variant | C/G;T | snv | 0.13 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.040 | 6 | 31354782 | non coding transcript exon variant | G/A | snv | 0.19 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.040 | 6 | 31298313 | intron variant | G/A | snv | 8.6E-02 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
6 | 31270541 | intron variant | G/A;C | snv |
|
0.800 | 1.000 | 1 | 2013 | 2013 | |||||||||||
|
1.000 | 0.120 | 6 | 31304544 | intron variant | G/A | snv | 7.4E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.160 | 6 | 31295974 | intron variant | T/C | snv | 0.20 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.720 | 1.000 | 3 | 2010 | 2018 | |||||||
|
0.827 | 0.240 | 6 | 31273255 | intron variant | A/G | snv | 0.15 |
|
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases | 0.720 | 1.000 | 2 | 2017 | 2018 | |||||||
|
0.807 | 0.200 | 6 | 31306778 | intron variant | C/T | snv | 0.12 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.710 | 1.000 | 2 | 2009 | 2014 |